Weekly epirubicin in patients with hormone-resistant prostate cancer

The aim of this study was to investigate the benefit of weekly epirubicin in the treatment of metastatic hormone-resistant prostate cancer. One hundred and forty-eight patients with metastatic hormone-resistant prostate cancer received weekly 30-min intravenous infusions of epirubicin 30 mg m(2) of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Petrioli, R, Fiaschi, A I, Pozzessere, D, Messinese, S, Sabatino, M, Marsili, S, Correale, P, Manganelli, A, Salvestrini, F, Francini, G
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364259/
https://ncbi.nlm.nih.gov/pubmed/12232753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600525
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados